Company intelligence / Profile preview

CBD Naturals

United States

Ownership: Private
Employees: ~11
Development stage: Other

Overview

CBD Naturals develops and markets hemp/cannabis‑derived and hops‑derived CBD consumer health and nutraceutical products (e.g., beverages, supplements) positioned for antioxidant, cellular health, and mood/wellness benefits, but it does not disclose formal clinical trials or drug‑like development programs.

Therapeutic areas: PsychiatryOther
Modalities: Small molecule
Industry: Food & Nutrition

Partnerships

Exclusive U.S. distribution partnership for a hops-derived CBD isolate with a “premier supplier” (name not disclosed) to supply ingredient to food, beverage and nutraceutical manufacturers.

Beyond the preview

Go deeper on CBD Naturals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CBD Naturals.

Explore the full profile